:
.., ..., . ..
.., ..., . .., 123 -
.., ..., 123 -
.., ..., , , Ļ
.., ..., . . , , Ļ
.., ..., . , , Ļ
: , , , ( , ), -10 N80.0. 25 ( 37,1 + 6) . 14 (56%), - 11 (44%) . 20 (80%), 3 (12%), ( ) - 2 (8%) .
3- , , , 100% , . 73,9% , .
- ( ), .
: , ,
, , . , , (71-87%) (21-47%) [1]. , ; . , 176 . .
|
|
( -10 N80.0) 70-90% [1,2]. , (, -, - .) . , , . , , ( ).
, , ( ), ( , ) - (). , ( ) ( 5 53%, , - 73%) [3,6,7].
(ASRM), , , [1]. , , [5]. , . , , ( ).
, , . , , . (c pc cp) γ - α[4].
.
.
( Ļ) 123 - , 34 .
|
|
: 1) 18-45 , ; 2) (); 3) ; 4) ; 5) .
: 1) , ; 2) , ; 3) ; 4) ; 4) , ; 5) , ; 6) 6 .
9 ( 2 , 6 , 1 , ).
25 23 45 ( 37,1), , .
, , 1 0,3 . 10 , 30 .
, 0,3 10 ( Ļ).
20 , . 4 : 1 2 ; -125 ( ) [1,2]; ; , ().
SPSS 15.0 (SPSS Inc, ) AtteStat 10.8.6 (). - ( 50 ). / (25;75 ) ( , , ). : t- ( 2- ) GLM-RM (General Linear Model Repeated Measures; 3- ), ( 2- ) ( GLM-RM). GLM-RM . 95% (). () .
.
25 23 45 ( 37,16 ), ( ( 2-5).
|
|
14 (56%), - 11 (44%) . 20 (80%), 3 (12%), ( ) - 2 (8%) .
9 (36%) ( 7 , 6 - 2 - ), 19 (76%) - .
13,2 .
22 (88%) 25 ( 1 13), 3 , 4 , 10 , 5 , 21 (84%) 25 ( 1 3), 14 , 6, . 16 (64%) 25 ( 1 10), 8, 4, 4 . 4 (16%) 25 , . 5 (20%) 25 , , .
4,6 ( 1).
1.
. [2011 ]. _ ( -: =0,830), ( -: =0,063/0,001, ). , _ , (25;75 ). , (25;75 ).
6 (24%) (4 , 2 ).
. 10 (40%) 25 , 1 (++), 9 (+). 20 (80%) . 23 (92%) , , 16 (64%) .
. 125, 19-9 .
100% . 25 ( ) . .
25 , .
( 2-5). 4 ( ) , , .
, 10 (40%) 25 , 1 (++), 9 (+). .
|
|
2 3.
2.
% | % | ||||
3.
. - , (25;75 ).
, , (p<0,001). ( ) , : 2 3 (p<0,001), 3 4 (=0,002), 4 5 (=0,025).
4 5.
4.
% | % | ||||
5.
( : p<0,001). ( ) , 2 3 (p<0,001) 4 5 (=0,011), 3 4 (=0,109).
6 7.
6.
% | % | ||||
7.
(-) , ( : p<0,001). 24 . ( ).
8, 9 10.
8.
% | % | ||||
(+) | |||||
. 3 18 (72%) 25 . , 4, ( 3) 16 (89%) 18 , 6 7 , 3 . ( ), 4 22 (88%) 25 . 5 . , 3- .
(=0,002), , , 2 5 (=0,004). 4,4 (95% 1,5 7,2) ( 9).
9.
. | N | ||
2 | |||
3 | |||
4 | |||
5 |
(<0,001), , , 2 3 (=0,026), 2 4 (=0,005) 2 5 (=0,014). 3 16 3 (95% 2 30), 4 22 3 (95% 7 36), 5 22 3 (95% 5 39). , 5- . ( % ) 3- 6,719,9%; 4- 10,021,6% (. ).
|
|
10.
. | N | ||
2 | |||
3 | |||
4 | |||
5 |
, ( -: <0,001). ( : =0,242), ( : =0,009) ( 11)
11. : ( )
, 3 . . ( -: <0,05). . ( : 125 =0,123; =0,061; 19-9 =0,642) ( 12-14).
12. 125 (/) .
(, , t- ) 2 5 (=0,037).
13. (/) .
14. 19-9 (/) .
, -- , .. ( ) , : 1) 6 (26,1%); 2) 13 (56,5%); 3) 4 (17,4%). , ( ) 73,9%, .
.
, 25 10 , : 1) - 100% ; 2) - 8% , - 92% ; 3) 36% , - 64% ; 4) 32% 68% ; 5) 12% , 88%; 6) ; 7) ( 125, 19-9) ; 8) 73,9% , .
:
1. : , ( ) /.., .. , .. , .. . //, 2013
2. .., .., .. : . / // . 2-. .: , 2006. 411 .
3. .., .. . // . 2011. 6. . 6677
4. .., .., .., .., .., .., .., C .., .., .., .. - // . 2009. 15,N 5. . 52-58.
5. .. . . / .. , .. , .. // -, 2007. .794
6. Descamps P., Andreeva E., Leng J., Salehpour S., Chapron Ch. The place of gonadotropin-releasing hormone agonists in the management of the endometriosis // Journal of endometriosis and pelvic pain disorders/ - Vol.6. - 1., Pp.1-11
7. Jia-Li Kang. Efficacy of gonadotropin-releasing hormone agonist and an extended-Interval dosing regimen in the treatment of patients with adenomyosis and endometriosis //Gynecol&Obstet. Investigatuon.- 2010. - 69.P.73-77
:
.., ..., . ..
127473/ , . , . 20, . 1
. +7(916) 127 02 68, e-mail: [email protected]
..., ..., . .., 123 -
143000. , . , , 15
. +7(916) 600 36 78, e-mail: [email protected]
.., ..., 123 -
143000. , . , , 15,
.+7 (495) 593-12-66, -mail: [email protected]
, ..., , , Ļ
129301. , . , .18, . 2, 3
. +7(495) 682 32 72, e-mail: [email protected]
, ...
. , , Ļ
129301. , . , .18, . 2, 3
. (495) 682 32 72, e-mail: [email protected]
, ...
. . , , Ļ
129301. , . , .18, . 2, 4
. (495) 682 32 72